Royal Bank Of Canada Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Royal Bank Of Canada

$579 Billion
Q3 2025

A detailed history of Royal Bank Of Canada transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Royal Bank Of Canada holds 26,618 shares of XPH stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

26,618

Previous 26,624 0.02%

Holding current value

$1.35 Million

Previous $1.08 Million 18.15%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$40.76 - $47.94 $244 - $287	-6 Reduced 0.02%	26,618 $1.28 Million
Q2 2025 Nov 21, 2025	SELL	$36.65 - $42.44 $27,634 - $31,999	-754 Reduced 2.75%	26,624 $1.08 Million
Q2 2025 Aug 14, 2025	SELL	$36.65 - $42.44 $27,634 - $31,999	-754 Reduced 2.75%	26,624 $1.08 Million
Q1 2025 Nov 21, 2025	BUY	$42.3 - $45.81 $32,147 - $34,815	760 Added 2.86%	27,378 $1.2 Million
Q1 2025 May 15, 2025	SELL	$42.3 - $45.81 $1 Million - $1.09 Million	-23,726 Reduced 46.43%	27,378 $1.2 Million

Q4 2024 Feb 14, 2025	BUY	$42.71 - $48.29 $1.12 Million - $1.26 Million	26,173 Added 104.98%	51,104 $2.2 Million
Q3 2024 Nov 14, 2024	SELL	$39.24 - $45.31 $507,647 - $586,175	-12,937 Reduced 34.16%	24,931 $1.11 Million
Q2 2024 Aug 14, 2024	BUY	$39.09 - $42.64 $330,545 - $360,563	8,456 Added 28.75%	37,868 $1.51 Million
Q1 2024 Nov 05, 2024	SELL	$41.38 - $45.49 $349,909 - $384,663	-8,456 Reduced 22.33%	29,412 $1.27 Million
Q1 2024 May 15, 2024	BUY	$41.38 - $45.49 $124,264 - $136,606	3,003 Added 11.37%	29,412 $1.27 Million
Q4 2023 Feb 14, 2024	SELL	$35.2 - $41.92 $807,980 - $962,231	-22,954 Reduced 46.5%	26,409 $1.1 Million
Q3 2023 Nov 14, 2023	BUY	$39.75 - $44.12 $518,260 - $575,236	13,038 Added 35.89%	49,363 $1.96 Million
Q2 2023 Aug 14, 2023	SELL	$39.1 - $42.57 $467,245 - $508,711	-11,950 Reduced 24.75%	36,325 $1.49 Million
Q1 2023 May 15, 2023	BUY	$39.61 - $44.25 $406,358 - $453,960	10,259 Added 26.99%	48,275 $1.98 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $43.59 $266,519 - $290,004	-6,653 Reduced 14.89%	38,016 $1.56 Million
Q3 2022 Nov 14, 2022	BUY	$39.59 - $44.52 $74,706 - $84,009	1,887 Added 4.41%	44,669 $1.79 Million
Q2 2022 Aug 15, 2022	SELL	$38.15 - $46.44 $728,550 - $886,864	-19,097 Reduced 30.86%	42,782 $1.8 Million
Q1 2022 May 16, 2022	SELL	$41.55 - $46.61 $58,959 - $66,139	-1,419 Reduced 2.24%	61,879 $2.8 Million
Q4 2021 Feb 14, 2022	BUY	$43.72 - $52.45 $566,305 - $679,384	12,953 Added 25.73%	63,298 $2.92 Million
Q3 2021 Nov 15, 2021	BUY	$46.51 - $53.1 $1.17 Million - $1.33 Million	25,080 Added 99.27%	50,345 $2.39 Million
Q2 2021 Aug 16, 2021	BUY	$48.16 - $53.09 $1.22 Million - $1.34 Million	25,265 New	25,265 $1.31 Million

Others Institutions Holding XPH

# of Institutions

Shares Held

2.73M

Call Options Held

12K

Put Options Held

22.2K

View Full List

About SPDR SER TR SPDR S&P PHARMACEU

Ticker XPH
Sector ETFs
Industry ETFs

More about XPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Spdr Ser Tr Spdr S&P Pharmaceu Transaction History